{
    "clinical_study": {
        "@rank": "48450", 
        "brief_summary": {
            "textblock": "To determine the clinical manifestation, diagnosis and treatment options of primary\n      hemifacial spasm in Chinese outpatient subjects"
        }, 
        "brief_title": "A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Hemifacial Spasm", 
        "condition_browse": {
            "mesh_term": [
                "Spasm", 
                "Hemifacial Spasm"
            ]
        }, 
        "detailed_description": {
            "textblock": "About 1000 outpatient subjects will be recruited. The inclusion criteria include clinically\n      diagnosed primary hemifacial spasm, male or female 18 to 80 years old and informed consent\n      has been obtained. The exclusion criteria include secondary hemifacial spasm, other\n      involuntary facial movement disorder, history of surgery of microvascular decompression of\n      the facial nerve and so on. The outcome measures include the percentage of the treatment\n      methods of HFS in outpatient subjects, aggrevated and relieved factors of HFS symptom,\n      concomitant symptoms of HFS and adverse events of botulinum toxin treatment in HFS patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1.Clinically diagnosed primary hemifacial spasm\n\n          1. Tonic and clonic contractions of muscles innervated by the unilateral facial nerve.\n\n          2. No other neurological disorder. 2.Male or female 18 to 80 years old 3.Informed\n             consent has been obtained\n\n        Exclusion Criteria:\n\n          1. Secondary hemifacial spasm: brainstem tumor, surgery, facial neuritis and so on.\n\n          2. Other involuntary facial movement disorder: facial synkinesia after facial palsy,\n             tics, myokymia and focal motor seizures.\n\n          3. History of surgery of microvascular decompression of the facial nerve.\n\n          4. Participation in another clinical study currently.\n\n          5. Not able to understand and answer questionnaire.\n\n          6. Investigator's opinion that the subject has a concurrent condition(s) that may\n             confound the study results."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "About 1000 Outpatient subjects from 15 centers across China."
            }
        }, 
        "enrollment": {
            "#text": "1003", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01728428", 
            "org_study_id": "116414"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hemifacial spasm", 
            "observational study", 
            "clinical manifestation", 
            "treatment", 
            "Chinese"
        ], 
        "lastchanged_date": "November 13, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100032"
                }, 
                "name": "Peking Union Medical College Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The percentage of the treatment methods of HFS in outpatient subjects", 
            "safety_issue": "No", 
            "time_frame": "November, 2012"
        }, 
        "reference": [
            {
                "PMID": "15050451", 
                "citation": "Tan EK, Fook-Chong S, Lum SY, Lim E. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci. 2004 Apr 15;219(1-2):151-5."
            }, 
            {
                "PMID": "9843077", 
                "citation": "Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998 Dec;21(12):1740-7."
            }, 
            {
                "PMID": "12145388", 
                "citation": "Tan NC, Chan LL, Tan EK. Hemifacial spasm and involuntary facial movements. QJM. 2002 Aug;95(8):493-500. Review."
            }, 
            {
                "PMID": "15175773", 
                "citation": "Au WL, Tan LC, Tan AK. Hemifacial spasm in Singapore: clinical characteristics and patients ' perceptions. Ann Acad Med Singapore. 2004 May;33(3):324-8. PubMed PMID: 15175773."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01728428"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "17558461", 
            "citation": "Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm. 2008;115(4):585-91. Epub 2007 Jun 11. Review."
        }, 
        "secondary_outcome": [
            {
                "measure": "Distribution of onset age of hemifacial spasm patients", 
                "safety_issue": "No", 
                "time_frame": "November, 2012"
            }, 
            {
                "measure": "Analysis of aggrevated and relieved factors of HFS symptom", 
                "safety_issue": "No", 
                "time_frame": "November, 2012"
            }, 
            {
                "measure": "Analysis of concomitant symptoms of hemifacial spasm", 
                "safety_issue": "No", 
                "time_frame": "November, 2012"
            }, 
            {
                "measure": "Adverse events of botulinum toxin treatment in hemifacial spasm", 
                "safety_issue": "Yes", 
                "time_frame": "November, 2012"
            }
        ], 
        "source": "Peking Union Medical College Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Peking Union Medical College Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}